BETAMETHASONE VALERATE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | BETAMETHASONE VALERATE |
| DrugBank ID | DB00443 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 186 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| lymphosarcoma | TxGNN Knowledge Graph | L5 |
| hodgkin's paragranuloma | TxGNN Knowledge Graph | L5 |
| heparin-induced thrombocytopenia (disease) | TxGNN Knowledge Graph | L5 |
| adrenocortical insufficiency | TxGNN Knowledge Graph | L5 |
| intravascular large b-cell lymphoma | TxGNN Knowledge Graph | L5 |
| epstein-barr virus-positive diffuse large b-cell lymphoma of the elderly | TxGNN Knowledge Graph | L5 |
| langerhans cell histiocytosis | TxGNN Knowledge Graph | L5 |
| leukemia, lymphocytic, susceptibility to | TxGNN Knowledge Graph | L5 |
| ankylosing spondylitis | TxGNN Knowledge Graph | L5 |
| chronic primary adrenal insufficiency | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11